BresMed’s new global HQ, at Steel City House in Sheffield, is the heart of the company’s worldwide operation. Commenting on the move CEO Nic Brereton said, “I am so proud to be expanding BresMed to these premium premises in the city. The building very much fits with our brand – it’s iconic with a quirky feel and, like us, it dares to be different.”
The company has come a long way since Nic moved into a one-person office in the city many years ago adding, “Actually, it was more a cupboard! However, it helped me launch the business.”
BresMed supports pharmaceutical companies and medical device manufacturers to identify, evaluate and demonstrate the clinical and economic value of their products to governments and other healthcare payers and providers.
From 2014 to 2017 a significant period of expansion saw employee numbers increase and offices open worldwide. Further office space was taken at North Church House until the decision was taken last year to begin the transition to Steel City House.
In July, employees joined health economics experts and business leaders at the grand opening. A tour of the premises followed a welcome speech from the Nic, “This is a vibrant working environment and we are absolutely delighted with how it looks.”
BresMed’s bond with Sheffield is clear when you see meeting rooms named after Sheffield icons such as Ennis, Jarvis and Hendos. The new head office is set up to allow great IT connectivity with the company’s other sites in Dublin, Manchester, Gurugram, Utrecht and Las Vegas.
This includes strong links with the University of Sheffield, including BresMed Chairman, Ron Akehurst, described by Brereton as the ‘Godfather of Health Economics’, also the founding Head of ScHARR – the School of Health and Related Research at the University of Sheffield. Many of BresMed’s employees hold degrees from the University of Sheffield or worked there prior to joining the company.
“The move to Steel City House signals an exciting time for BresMed’s continued growth, and we are now a major part of a global industry that helps ensure the cost effectiveness of healthcare”, says Akehurst.
“Billions are spent worldwide on healthcare and health products. We understand and continue to study the economics of the process from laboratory to patient, providing governments and insurers with robust data to help them make lifechanging funding decisions.”
For more information, visit www.bresmed.com